PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 207 filers reported holding PTC THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57,670 | -3.0% | 1,418 | +15.5% | 0.01% | -11.1% |
| Q1 2023 | $59,484 | +44.3% | 1,228 | +13.7% | 0.01% | +50.0% |
| Q4 2022 | $41,224 | -23.7% | 1,080 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $54,000 | +25.6% | 1,080 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $43,000 | +7.5% | 1,080 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $40,000 | -7.0% | 1,080 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $43,000 | +7.5% | 1,080 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $40,000 | -13.0% | 1,080 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $46,000 | -9.8% | 1,080 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $51,000 | -10.5% | 1,080 | +16.1% | 0.01% | -11.1% |
| Q4 2020 | $57,000 | +119.2% | 930 | +66.4% | 0.01% | +80.0% |
| Q3 2020 | $26,000 | +100.0% | 559 | +124.5% | 0.01% | +66.7% |
| Q2 2020 | $13,000 | +18.2% | 249 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | – | 249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |